APA

Wang R., Yang Q., Luo R., Peng Y., Dai S., Zhang X., Chen H., Cui X., Liu Y., Huang J., Chang J. & Zheng Y. (20150514). Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro. : PloS one.

Chicago

Wang Rui-Rui, Yang Qing-Hua, Luo Rong-Hua, Peng You-Mei, Dai Shao-Xing, Zhang Xing-Jie, Chen Huan, Cui Xue-Qing, Liu Ya-Juan, Huang Jing-Fei, Chang Jun-Biao and Zheng Yong-Tang. 20150514. Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro. : PloS one.

Harvard

Wang R., Yang Q., Luo R., Peng Y., Dai S., Zhang X., Chen H., Cui X., Liu Y., Huang J., Chang J. and Zheng Y. (20150514). Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro. : PloS one.

MLA

Wang Rui-Rui, Yang Qing-Hua, Luo Rong-Hua, Peng You-Mei, Dai Shao-Xing, Zhang Xing-Jie, Chen Huan, Cui Xue-Qing, Liu Ya-Juan, Huang Jing-Fei, Chang Jun-Biao and Zheng Yong-Tang. Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro. : PloS one. 20150514.